Facebook
Twitter
Telegram
Report an ErrorLumos Pharma Financial Ratios 2011-2024 | LUMO
Annual Financial Ratios Lumos Pharma
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
P/E |
-0.7 | -1.0 | -2.7 | -25.2 | -0.3 | -0.1 | -0.4 | -0.4 | -1.9 | 9.9 | -29.8 | -10.3 | -2.3 |
P/S |
12.0 | 20.1 | 362.4 | 849.0 | 14.4 | 0.5 | 1.0 | 1.1 | 1.1 | 5.9 | 850.3 | 142.9 | 22.6 |
EPS |
-4.2 | -3.7 | -3.6 | -0.9 | -1.1 | -1.4 | -2.3 | -2.9 | -1.4 | 3.5 | -1.2 | -1.1 | -3.0 |
EV (Enterprise Value) |
2.85 M | -12.7 M | -129 K | 56.4 M | -75.6 M | -99 M | -100 M | -48.3 M | -95.5 M | 863 M | 880 M | 232 M | 14.4 M |
EBITDA per Share |
-4.49 | -3.82 | -3.74 | -3.1 | -5.24 | -14.8 | -20.5 | -27.5 | -10.1 | 4.26 | -1.2 | -1.08 | -2.87 |
EV/EBITDA |
0.0 | -1.7 | -0.2 | 1.9 | 1.8 | 1.0 | 3.7 | 8.6 | -30.7 | -10.7 | -2.5 | ||
PEG |
0.06 | 0.04 | 0.1 | -8.67 | -0.02 | -0.0 | -0.02 | 0.0 | 0.0 | 0.02 | 3.01 | -0.17 | -0.03 |
P/B |
0.9 | 0.5 | 0.9 | 1.2 | 0.2 | 0.1 | 0.2 | 0.3 | 0.4 | 5.0 | 15.9 | 13.4 | 1.1 |
P/CF |
-0.8 | -1.2 | -2.8 | -6.2 | -0.4 | -0.2 | -0.6 | -0.6 | -2.8 | 9.5 | -34.2 | -11.1 | -3.2 |
ROE % |
-124.64 | -52.13 | -34.20 | -4.86 | -54.50 | -46.55 | -47.47 | -65.77 | -20.63 | 50.48 | -53.46 | -130.09 | -49.19 |
ROA % |
-83.75 | -42.97 | -30.34 | -4.39 | -777.94 | -40.93 | -39.82 | -48.73 | -18.48 | 43.21 | -44.19 | -79.24 | -37.39 |
ROCE % |
-134.09 | -53.77 | -32.93 | -22.56 | -1058.74 | -51.14 | -45.93 | -66.32 | -16.50 | 55.19 | -46.70 | -87.74 | -47.89 |
Current Ratio |
3.0 | 5.7 | 8.8 | 10.4 | 4.0 | 14.4 | 8.0 | 4.4 | 14.0 | 9.2 | 16.5 | 8.0 | 4.0 |
DSO |
- | - | - | - | 13.6 | 23.4 | 133.9 | 311.3 | 28.7 | 7.9 | 443.5 | 42.4 | 0.2 |
DIO |
- | - | - | - | - | - | - | - | - | - | - | - | - |
DPO |
- | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Cycle |
- | - | - | - | - | - | - | - | - | - | - | - | - |
Cash Conversion Cycle |
- | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Quarterly Financial Ratios Lumos Pharma
| 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
EPS |
-1.29 | - | -1.04 | -1.09 | -0.89 | - | -0.86 | -0.94 | -0.92 | - | -0.9 | -0.99 | -1.04 | - | 0.21 | -0.65 | -0.14 | -0.22 | -2.56 | -0.27 | -0.27 | -0.28 | -0.2 | -0.47 | -0.49 | -0.37 | -0.69 | -0.57 | -0.72 | -0.46 | -0.54 | -1.12 | -0.82 | -0.75 | -0.55 | -0.49 | 0.4 | 4.29 | -0.2 | -0.33 | -0.33 | -0.31 | -0.32 | -0.28 | -0.33 | -0.3 | -0.28 | -0.31 | -0.23 | -0.44 | -1.09 | -1.2 | -1.07 |
EBITDA per Share |
-1.34 | - | - | - | -0.97 | - | -0.9 | -0.95 | -0.92 | - | -0.87 | -0.97 | -1.02 | - | -0.82 | -0.79 | -2.38 | -7.38 | -1.99 | -1.92 | -1.59 | -0.29 | -0.38 | -0.46 | -0.49 | -0.38 | -0.66 | -0.55 | -0.71 | -0.48 | -0.52 | -1.15 | -0.86 | -0.51 | -0.51 | -0.53 | 0.47 | 5.33 | -0.44 | -0.31 | -0.33 | -0.3 | -0.29 | -0.26 | -0.33 | -0.3 | -0.25 | -0.29 | -0.23 | -0.28 | -0.94 | -1.11 | -1.02 |
ROE % |
-127.10 | -57.83 | -68.54 | -55.86 | -45.93 | -30.67 | -38.62 | -35.87 | -33.92 | -24.45 | -22.94 | -13.47 | -9.48 | -2.79 | 11.12 | 14.10 | 23.01 | 26.26 | 34.87 | 23.96 | 4.60 | -14.84 | -46.40 | -53.58 | -49.58 | -47.47 | -48.88 | -47.27 | -61.25 | -60.87 | -61.46 | -57.58 | -39.76 | -20.63 | 51.33 | 56.62 | 59.32 | 49.07 | -25.67 | -36.75 | -44.39 | -53.46 | -74.91 | -93.62 | -116.68 | -130.09 | -110.64 | -72.42 | -49.17 | -32.76 | 5.58 | -11.95 | -10.60 |
ROA % |
-87.79 | -44.75 | -53.91 | -45.68 | -39.02 | -26.62 | -33.65 | -31.53 | -29.94 | -21.81 | -20.44 | -12.04 | -8.60 | -2.52 | -152.19 | -201.86 | -244.20 | -282.56 | -140.95 | -98.31 | -65.04 | -40.93 | -40.43 | -46.19 | -42.23 | -39.82 | -39.97 | -37.45 | -46.73 | -48.73 | -50.87 | -49.26 | -37.17 | -18.48 | 43.30 | 48.16 | 50.75 | 41.75 | -21.55 | -30.64 | -36.83 | -44.19 | -54.26 | -62.63 | -74.04 | -79.24 | -69.78 | -58.14 | -45.78 | -37.39 | -8.24 | -9.08 | -8.06 |
ROCE % |
-13.69 | -27.37 | -37.61 | -34.17 | -44.00 | -28.86 | -36.33 | -33.55 | -31.78 | -23.01 | -28.85 | -27.23 | -24.78 | -15.70 | -1.04 | 9.35 | 19.33 | 27.20 | 39.92 | 23.05 | 4.14 | -14.79 | -51.03 | -51.89 | -47.89 | -45.93 | -47.29 | -46.31 | -61.00 | -61.42 | -58.49 | -54.00 | -36.59 | -16.50 | 63.06 | 64.44 | 67.98 | 57.31 | -26.84 | -32.69 | -39.01 | -46.70 | -58.57 | -68.46 | -81.63 | -87.74 | -79.39 | -51.69 | -39.57 | -31.72 | 5.64 | -11.65 | -10.32 |
Current Ratio |
2.6 | 3.0 | 3.9 | 4.4 | 5.7 | 5.7 | 6.9 | 7.8 | 8.2 | 8.8 | 8.6 | 8.7 | 10.8 | 10.3 | 10.3 | 10.3 | 10.3 | 3.8 | 3.8 | 3.8 | 3.8 | 8.3 | 8.3 | 8.3 | 8.3 | 6.2 | 6.2 | 6.2 | 6.2 | 3.9 | 3.9 | 3.9 | 3.9 | 9.6 | 9.6 | 9.6 | 9.6 | 6.7 | 6.7 | 6.9 | 6.9 | 5.8 | 5.8 | 5.8 | 5.8 | 2.6 | 2.6 | 2.6 | 2.6 | 4.2 | 4.2 | 4.2 | 4.2 |
DSO |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 42.4 | 564.7 | 141.9 | 54.0 | 223.7 | 96.5 | 64.2 | 34.6 | 66.0 | 10.6 | 2.0 | 121.1 | 1599.5 | 689.0 | 412.2 | 457.3 | 522.3 | 230.2 | - | - | - | - | - | - | - | - |
DIO |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
DPO |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Cycle |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 42.4 | 564.7 | 141.9 | 54.0 | 223.7 | 96.5 | 64.2 | 34.6 | 66.0 | 10.6 | 2.0 | 121.1 | 1599.5 | 689.0 | 412.2 | 457.3 | 522.3 | 230.2 | - | - | - | - | - | - | - | - |
Cash Conversion Cycle |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 42.4 | 564.7 | 141.9 | 54.0 | 223.7 | 96.5 | 64.2 | 34.6 | 66.0 | 10.6 | 2.0 | 121.1 | 1599.5 | 689.0 | 412.2 | 457.3 | 522.3 | 230.2 | - | - | - | - | - | - | - | - |
All numbers in USD currency